Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Tuberous Sclerosis × Propranolol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Hemangioma 9 Hemangioma, Capillary 6 Melanoma 5 Breast Neoplasms 4 Sarcoma 3 Hemangiosarcoma 3 Fallopian Tube Neoplasms 3 Prostatic Neoplasms 2 Pancreatic Neoplasms 2 Multiple Myeloma 2 Hemangioma, Cavernous, Central Nervous System 2 Carcinoma, Ovarian Epithelial 2 von Hippel-Lindau Disease 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Ulcer 1 Tuberous Sclerosis 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Spinal Cord Neoplasms 1 Smoldering Multiple Myeloma 1 Skin Neoplasms 1 Sarcoma, Kaposi 1 Recurrent respiratory papillomatosis 1 Recurrence 1 Papilloma 1 Ovarian Neoplasms 1 Neuroblastoma 1 Neoplasm Metastasis 1 Lymphatic Metastasis 1

Interventions

Sirolimus 12 Everolimus 10 Activator Appliances 3 Vigabatrin 2 carbon-11 acetate 1 Urination 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Simvastatin 1 Sertraline 1 Selective Serotonin Reuptake Inhibitors 1 Propranolol 1 Phlebotomy 1 Genetic Testing 1 Fluid Therapy 1 Doxycycline 1 Curcumin 1 Calcitriol 1 Aspirin 1 Anticonvulsants 1 Actigraphy 1 Acceptance and Commitment Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02104011 2018-01-23

STBETA

University Hospital, Bordeaux

Phase 2 Completed

Tuberous Sclerosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡